Virtus LifeSci Biotech Clinical Trials ETF (BBC) |
| 29.64 0.66 (2.28%) 10-09 16:00 |
| Open: | 29.22 |
| High: | 29.67 |
| Low: | 29.15 |
| Volume: | 23,955 |
| Market Cap: | 18(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 34.65 |
| Resistance 1: | 29.67 |
| Pivot price: | 27.09 |
| Support 1: | 25.97 |
| Support 2: | 23.69 |
| 52w High: | 31.65 |
| 52w Low: | 13.42 |
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 09 Sep 2025
Best-Performing ETFs of Last Week - Yahoo Finance
Wed, 07 May 2025
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
Wed, 17 Apr 2024
The 5 Best Biotech ETFs of 2024 - ETF.com
Mon, 24 Apr 2023
ALPS’ Biotech ETF SBIO Week's Top Performer - ETF Trends
Tue, 20 Sep 2022
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Mon, 13 Sep 2021
Biotech Stocks Have Colds, but They Can Heal - ETF Trends
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
